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Nanoparticles arise from a wide variety of natural and man-made sources and
have a diverse array of biological, chemical, and physical properties. The toxicity of
these particles can be roughly divided into two categories: 1) the enhanced delivery
of toxic agents 2) toxicity induced the properties of the particle itself. The use of
nanoparticles to provide enhanced delivery of chemotherapeutics is presented
followed by a discussion of the size-based effects of electron transfer and physical
membrane disruption .  2009 John Wiley & Sons, Inc. WIREs Nanomed Nanobiotechnol 2009 1
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Many challenges face the scientific communityas it endeavors to understand the biological
roles of nanoparticulate materials.1,2 First, no one
traditional scientific field contains the theoretical
knowledge and tools necessary to both characterize
the nanomaterials and explore their interactions
with biological structures. The ideas and methods
of biology, biochemistry, chemistry, and physics
must all be brought to bear on the problem.
Second, nanomaterials arise from a wide variety of
natural and man-made sources, have an incredible
array of chemical and physical properties, and
are difficult themselves to characterize fully. In
particular, the surface composition and properties of
the particles are clearly important, but often unknown,
especially once introduced in the biological system.3,4
Third, biological processes as basic as endocytosis,
apoptosis, and vacuole formation, all examples that
are likely highly relevant to the biological activity of
nanoparticles, are themselves only crudely understood
for even the most common cell types. This is
particularly true if one asks the question of what is
occurring in these processes at the nanoscale; one scale
of action likely to be disrupted by the nanoparticles.
The nascent field of nanobiology, as a complement
to microbiology, has yet to develop. Given these
constraints arising from a combination of our training
as scientists and our limited knowledge in all scientific
fields regarding this problem, the development of an
∗Correspondence to: mbanasza@umich.edu
Chemistry Department and Macromolecular Science and Engi-
neering, Programs in Applied Physics and Biophysics, Graham
Environmental Sustainability Institute, University of Michigan, Ann
Arbor, MI, 48109-1055, USA
DOI: 10.1002/wnan.027
understanding of nanotoxicology presents a grand
challenge to the scientific community. However, given
the importance of natural nanomaterials in biological
structure and function, and given the rapidly influx of
synthetic nanomaterials into the environment caused
by human activity, it is a challenge we must embrace.
The toxic action of nanoparticle interactions
with biological systems can be roughly divided
into two categories. The first category includes the
enhanced delivery of chemical agents known to be
toxic. The second category involves the toxic effects
of comparatively benign materials derived from the
size-related disruption of biological structures. These
two general classes of toxic behavior will be reviewed
below.
ENHANCED DELIVERY OF TOXIC
MATERIALS
Nanoparticles have the potential to enhance the
toxicity of materials and allow them to have a
greater lethal effect for a given level of exposure.
This effect has the potential to be harmful or
beneficial. Many of the published examples have
focused on the positive aspects of this effect for
biomedical applications. For example, biological
macromolecules ∼20–160 KDa have been shown to
exhibit the enhanced permeation and retention (EPR)
effect which provides a mechanism for concentration
of nanoscale materials in tumors.5 This has been
demonstrated for a wide variety of other nanoparticle
materials including poly(ethylene glycol)-coated gold-
silica nanoshells,6,7 ultrafine formulations of polymer
and sol–gel materials,8 dendrimeric polymers,9 shell
cross-linked micelles,10 and micelles.11 This effect
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appears to be based upon the presence of an enhanced
and leaky vasculature present in the tumor combined
with a reduced clearance rate for nanoparticles.
Oberdörster et al. have noted that particle size has a
substantial impact on where inhaled materials become
located within the lung structure.2 Furthermore,
transport of particles from the nasal membranes of
rats to the brain has also been observed.12 It is
not clear if these localization effects, and the EPR
effects mentioned above, should be thought of solely
as dynamic transport-based localization dependent on
particle size or if the localization, and in particular
the reduced clearance rates, may also be related to
disruption of membranes or other biological structures
in these regions.
Another method by which nanoparticles can
increase the toxicity of materials is by multivalent
binding effects associated with cellular receptors.
Multivalency effects are well known for natural bio-
logical nanoparticles as exemplified by cell–cell, virus-
cell, and bacteria-cell interactions.13–16 Examples for
synthetic nanoparticles made more toxic by this
effect include folic acid-targeting poly(amidoamine)
dendrimers.17,18 In this case, the multivalent bind-
ing leads to a local concentration of a toxic
agent (methotrexate) leading to increased toxicity
for the targeted cells.19 A variety of other targeted
nanoparticle systems likely operating by multivalent
mechanisms have also been published. These stud-
ies include HER2-targeted and disaccharide-targeted
gold nanoparticles for photothermal therapy.20,21 The
above examples employ the enhanced toxicity against
cancer cells for a therapeutic effect. Clearly, it would
also be possible for this effect to be employed against
desired healthy cells in cases where these multivalent
agents would be regarded as particularly lethal toxins.
SIZE-BASED PHYSICAL DISRUPTION
OF BIOLOGICAL STRUCTURES
Size-based Mediation of Electron Transfer
Events
Particle-size can lead to the formation of electronic
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FIGURE 1 | Poly(amidoamine) (PAMAM) dendrimer interactions with biological membranes. Left panel: Atomic force microscopy (AFM)
observation of dimyristoylphoshatidylcholine (DMPC) supported lipid bilayers (a), (c), and (e) before and after incubation with (b) G7-NH2,
(d) G5-NH2, and (f) G5-Ac PAMAM dendrimers, respectively. Middle panel: Space-filling models of chemical structures of (a) G7-NH2, (b) G5-NH2,
and (c) G5-Ac PAMAM dendrimers. Right panel: Lactate dehydrogenase (LDH) leakage as a result of cell exposure to PAMAM dendrimers. (a) Size
effect of G7-NH2 and G5-NH2 on the LDH leakage out of KB and Rat2 cells after incubation at 37
◦C for 3 h and (b) surface group dependency on the
LDH leakage at different temperatures. Note that larger dendrimers (G7-NH2) induce formation of new nanoscale holes in the bilayers as seen in the
AFM images and cause more amount of LDH leakage out of live cells than G5-NH2. G5-NH2 dendrimers do not cause new hole formation in the lipid
bilayers but instead expand preexisting defects. In contrast, G5-Ac dendrimers do not cause hole formation, expansion of preexisting defects, or LDH
leakage out of live cells. (Reprinted with permission from Ref 33. Copyright 2007 American Chemical Society) .
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material. The electronic states present in nanoscale
materials have the potential to undergo electron
transfer reactions ranging from the generation of
reactive oxygen species (ROS) to direct interference
desired in biological electron transfer reactions. This
mechanism has been proposed to be an important
pathway for toxicity for a variety of nanoparticles
including nano–C60,22 III–V and II–VI quantum
dots (QD),23 and titania.24,25 There has been some
debate in the literature regarding the origin of
ROS production, particularly whether the ROS were
generated by the nanoparticle itself or by cellular
activity physically disrupted by the nanoparticle.26
However, recent studies continue to focus on ROS
production as a significant marker of toxicity for a
wide variety of nanoparticles.27–29
Size-based Mediation of Membrane
Disruption Events
The second category of nanoparticles interacts with
the biological system because of the interaction of
the particle surface and biological structure leading
to disruptive structural changes. Most commonly,
disruption of the cell plasma membranes has been
observed as a function of dye diffusion or cytosolic
enzyme leakage assays. These approaches have been
employed for a variety of materials including cell pen-
etrating peptides30,31 and polymers (Figure 1).32–34
A combination of atomic force microscopy
(AFM) on model membrane surfaces,35–38 cytosolic
enzyme leakage, dye diffusion assays, and confocal
microscopy;32,38–40 and electron paramagnetic reso-
nance, transmission electron microscopy, and light
scattering studies41 have been used to study the dis-
ruption mechanism of lipid bilayers and cell plasma
membranes by polycationic polymers.33 These stud-
ies clearly demonstrate that polycationic nanoparticles
are particularly effective in causing cell membrane per-
meability. In addition, they appear to continue to dis-
rupt activities within the cell and subsequently cause
additional toxicity by means of ROS production.26 On
the basis of the interaction of the cationic nanoparti-
cles with supported lipid bilayers, it appears that hole
formation is one possible mechanism for the induction
of permeability in the cell membranes.33 However,
based upon recent coarse-grained molecular mechan-
ics/molecular dynamics simulations of nanoparticle
membrane interactions, one must also consider the
formation of water channels by nanoparticles that
lodge in the center of the bilayer42 as a possible
permeation mechanism (Figure 2). In addition to poly-
cationic polymers, other polycationic nanoparticles
have also been observed to cause membrane perme-
ability and to readily transport into cells. This has
been demonstrated for both gold nanoparticles43,44
and QD45,46 modified with amine functional groups.
FIGURE 2 | (a) A snapshot at the
beginning (0 ns) of the simulation of
system G5-1 (100% acetylated).
Snapshots at the end (0.5 µs) of
simulations of systems (b) G5-1, (c) G5-2
(50% acetylated), (d) G5-3
(un-acetylated), (e) G5-4 (un-acetylated,
500 mM NaCl), (f) G5-5 (un-acetylated,
low temperature), (g) G3-1 (100%
acetylated), and (h) G3-2 (un-acetylated).
Black dots represent dendrimers, and
blue dots represent head groups of the
dipalmitoylphosphatidyl choline bilayer.
The explicit water and ions are omitted
for clarity. The images were created with
visual molecular dynamics (VMD).
(Reprinted with permission from Ref 42.
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FIGURE 3 | Confocal scanning
microscopy of porcine skin treated with
QD 565 for 8 h. (a-c) QD-PEG; (d-f)
QD-PEG-NH2; (g-i) QD-COOH. DIC
channel (a, d, g) provides an
unobstructed view of the skin layers.
Confocal-DIC overlay with the green
QD fluorescence channel (b, e, h)
shows QD localization within the
epidermis or dermis (arrows).
Fluorescence intensity scan of the QD
emission (c, f, i). QD 565 are localized
in the epidermal (PEG and COOH
coatings) or dermal (NH2 coating)
layers by 8 h. Scale bars equal 50 µm.
(Figure revised with permission from
Ref 47. Copyright 2006 Oxford Press).
NANOPARTICLE INTERACTION WITH
SKIN
The role of membrane disruption in nanoparticle
localization and retention in tissue is largely unknown.
Exposure of porcine skin to spherical 4.6 nm
(QD 565) and ellipsoidal 6 × 12 nm (QD 655)
with poly(ethylene glycol) (neutral), carboxylic acids
(anionic), and poly(ethylene glycol-amine) (cationic)
coatings resulted in penetration of the stratum
corneum and localization within the epidermal and
dermal layers (Figure 3).47 Subsequent work with
neonatal human epidermal keratinocytes (NHEK)
suggests that endocytosis processes are involved in
particle uptake but inhibitory effects were only
about 50% indicating that other mechanisms besides
macropinocytosis are active for transport of material
into the cell.48 Regardless, endocytosis alone does not
provide a simple explanation for how nanoparticle
penetrate 50–100 µm into skin. Do the particles
transport through the cells or can they diffuse
in between cell junctions? To what degree are
biological process such as endocytosis triggered by
the nanoparticles and to what extent do the particles
interact with the membranes and enhance diffusion
rates of materials across the membrane?
THE ROLE OF NANOPARTICLE
AGGREGATION
Nanoparticles can have a complex aggregation
behavior in aqueous solution and this in turn can
have a substantial impact upon the particle toxicity.
One of the most dramatic example of aggregation
effects in aqueous systems has been observed for
C60. When C60 is added to water, an aggregate of
10–1000 C60 molecules forms. It is this aggregate
which has been proposed to be the active form of
this nanoparticle in water.22 Similarly, fullerols have
also been observed to cluster in water making 100 nm
or larger aggregates. Aggregation effects have also
been noted to play a role in the toxicity of SiO2,
TiO2, and ZnO nanoparticles.49 Natural biological
nanoparticles, including the general class of cell
penetrating peptides, have long been recognized to act
via clustering events that occur on the cell membrane50
although nanoscale and molecular level details of these
events have only recently been directly elucidated.51,52
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It is anticipated that nanoparticle aggregation in a
variety of forms will play a very important role in
biological activity. One aspect of aggregation in par-
ticular, interaction with proteins in serum, has recently
been the subject of substantial activity.
INTERACTIONS WITH NATIVE
PROTEINS—DO NANOPARTICLES
ACQUIRE A PROTEIN CORONA?
The surface modification that occurs to nanoparti-
cles upon entering tissue or blood remains largely
unknown. Both the surface composition and the flex-
ibility of the surface molecules are likely to play
an important role in the types of biological species
favored to bind and the strength of that binding event.
Cleary, the natural nanoparticles known as enzymes
are able to function in a variety of biological environ-
ments without being inactivated by the formation of a
corona of surrounding protein. Similarly, the success
of in vivo targeting of intravenously injected nanopar-
ticles to the cytoplasm cancer cells17 indicates that if
corona is present for these species, it is sufficiently
labile to allow nanoparticle binding and endocytosis.
However, for some types of nanoparticles, it is possible
that strong surface binding could result in mechanisms
for the aggregation of these materials and a new man-
ner in which they would then be presented to the
cell or released into the environment. Two recent
reports exploring this effect for acrylamide nanopar-
ticles did detect the presence of a protein corona.3,4
For blood, initial binding by human serum albumin
followed displacement by apolipoproteins has been
proposed. Clearly, these observations need further
exploration for a wider variety of nanoparticles and
possible protein adsorbates. The effect of the corona
on nanoparticle toxicity needs to be tested.
SUMMARY
Gaining an overall understanding of nanoparticle traf-
ficking events in biological systems is a grand challenge
that must be met to understand the role of natural
nanoparticles in regular biological activity and the
positive and negative roles that synthetic nanoparti-
cles will play. Given the extensive roles of membranes
in biology ranging from skin to lungs to cell plasma
membranes to mitochondrial membranes, interactions
with nanoparticles are unavoidable and therefore must
be better understood. The direct disruptive effects of
nanoparticles on these biological systems, and the
ability of nanoparticles to pass through membranes
designed to act as barriers, create many opportuni-
ties for toxic effects to occur. The large body of data
already present in the literature regarding membrane
disruption33 indicates that nanoparticles will have
toxic biological effects. We must work to understand
them so that the many beneficial aspects of nanotech-
nology give rise to a minimum number of unintended
negative consequences.
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